Search all ALPCO products, resources, and website information

Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
ALPCO-GeneProof ADLM 2024
Let us fuel your day at ADLM!Enjoy specialty coffee at our booth on Day 1 and indulge in sweet treats on Day 2 while you explore our innovative solutions.Skip the crowd and reserve your time for a demonstration or individual meeting with a member of our team.IMMUNOASSAY SOLUTIONS FOR GASTROENTEROLOG...
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
Class IA PI3K Inhibitor Cancer Therapies
Date: August 16, 2016 Author: Andrea Tarbet, Product Marketing Associate at ALPCO Bruton’s tyrosine kinase (BTK) inhibitors are not the only kinase inhibitors to enter the fight against B cell cancers. Since there are numerous subtypes of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), p...
Summer 2021 Diabetes Research Travel Grant Recipient
Salem, NH, October 12, 2021 [caption id="attachment_7170" align="alignleft" width="229"] Mollie Huber, Summer 2021 Diabetes Research Travel Grant Recipient[/caption] FOR IMMEDIATE RELEASE – ALPCO’s Summer 2021 Diabetes Research Travel Grant has been awarded to Mol...
MacroArray Diagnostics GmbH (MADx) partners with ALPCO to offer a fully automated sample-to-answer multiplex allergy test solution to the North American market
FOR IMMEDIATE RELEASE Salem, NH – February 1, 2022: ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together they offer a comprehensive line of testing ...
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50+ unique molec...
Food Intolerance Testing with MADx
ALPCO has partnered with MacroArray Diagnostics, MADx, to offer a comprehensive testing solution for IgG-based food intolerances. MADx’ multiplex food test offers a complete repertoire of relevant food antigens, including dairy, nuts, fruits/vegetables, spices and also superfoods such as alo...
The Role of IgE and IgG in Allergy Testing
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives...
Diagnostic Testing in GI Health
 60 to 70 million Americans are affected by gastrointestinal (GI) diseases and disorders each year. The estimated annual U.S. cost associated with GI disorders is over 140 billion dollars. Gl diseases and disorders can have a significant impact on quality of life, often contributing to anxiety ...
FOX Food Xplorer
Simultaneous measurement of specific IgG (slgG) against 286 food antigens, including 13 different food groups. -Test for common and novel foods-Detect potential for IgG-mediated food intolerance-Investigate adaptive food tolerance